{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T19:59:07Z","timestamp":1772913547078,"version":"3.50.1"},"reference-count":192,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.critrevonc.2012.09.003","type":"journal-article","created":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T01:17:30Z","timestamp":1348967850000},"page":"104-129","source":"Crossref","is-referenced-by-count":74,"title":["Tissue biomarkers as prognostic variables of cervical cancer"],"prefix":"10.1016","volume":"86","author":[{"given":"Angiolo","family":"Gadducci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"Guerrieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2012.09.003_bib0005","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2050","article-title":"The natural history of cervical HPV infection: unresolved issues","volume":"7","author":"Woodman","year":"2007","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0015","first-page":"125","article-title":"Histopathology of cervical precursor lesions and cancer","volume":"20","author":"Lax","year":"2011","journal-title":"Acta Dermatovenerologica Alpina, Pannonica et Adriatica"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0020","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1054\/bjoc.2000.1523","article-title":"Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case\u2013control study nested within the Manchester cohort","volume":"83","author":"Deacon","year":"2000","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2007\/914823","article-title":"The epidemiology of human papillomavirus infection and cervical cancer","volume":"23","author":"Bosch","year":"2007","journal-title":"Disease Markers"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0030","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"International Collaboration of Epidemiological Studies of Cervical Cancer","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/RHU.0b013e3181df5261","article-title":"Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression?","volume":"16","author":"Klumb","year":"2010","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0040","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/CCO.0b013e32833cff4f","article-title":"Issues in cervical cancer incidence and treatment in HIV","volume":"22","author":"Einstein","year":"2010","journal-title":"Current Opinion in Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/09513590.2011.558953","article-title":"Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature","volume":"27","author":"Gadducci","year":"2011","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0050","first-page":"65","article-title":"Prevalence of Chlamydia trachomatis and herpes simplex virus 2 in cervical carcinoma associated with human papillomavirus detected in paraffin-sectioned samples","volume":"30","author":"Kwa\u015bniewska","year":"2009","journal-title":"European Journal of Gynaecological Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0060","first-page":"CD008285","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis","volume":"20","author":"Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC)","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.20.1.179","article-title":"Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study","volume":"20","author":"Benedetti-Panici","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0070","first-page":"CD001774","article-title":"Neoadjuvant chemotherapy for locally advanced cervix cancer","volume":"2","author":"Neoadjuvant Chemotherapy for Cervical Cancer Meta-Analysis Collaboration (NACCCMA)","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0075","first-page":"1399","article-title":"Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study","volume":"20","author":"Gadducci","year":"2010","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0080","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/gyno.1996.0327","article-title":"An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"63","author":"Look","year":"1996","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ygyno.2003.11.020","article-title":"Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?","volume":"92","author":"Creasman","year":"2004","journal-title":"Gynecologic Oncology"},{"issue":"November (Suppl. 1)","key":"10.1016\/j.critrevonc.2012.09.003_bib0090","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0020-7292(06)60030-1","article-title":"Carcinoma of the cervix uteri","volume":"95","author":"Quinn","year":"2006","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0095","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1525-1438.2006.00379.x","article-title":"Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy","volume":"16","author":"Narayan","year":"2006","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2009.08.006","article-title":"Validation of existing prognostic models in patients with early-stage cervical cancer","volume":"115","author":"Biewenga","year":"2009","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0105","first-page":"4387","article-title":"Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy","volume":"9","author":"Tsang","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2007.05.069","article-title":".Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial","volume":"70","author":"Wolfson","year":"2008","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0115","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/IGC.0b013e3182126f85","article-title":"DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study","volume":"21","author":"Susini","year":"2011","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0959-8049(99)00292-0","article-title":"Control of the cell cycle and apoptosis","volume":"35","author":"Lundberg","year":"1999","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0125","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1242\/jcs.01227","article-title":"Molecular mechanisms of E2F-dependent activation and pRB-mediated repression","volume":"117","author":"Frolov","year":"2004","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-642-71941-7_2","article-title":"Inhibitors of the Cip\/Kip family","volume":"227","author":"Hengst","year":"1998","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0135","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/35096061","article-title":"The INK4a\/ARF network in tumour suppression","volume":"2","author":"Sherr","year":"2001","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0140","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1349-7006.2009.01488.x","article-title":"The cell death machinery governed by the p53 tumor suppressor in response to DNA damage","volume":"101","author":"Yoshida","year":"2010","journal-title":"Cancer Science"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/excr.2001.5171","article-title":"Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis","volume":"265","author":"Gao","year":"2001","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0155","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2001-2-7-reviews3009","article-title":"Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs","volume":"2","author":"Verhagen","year":"2001","journal-title":"Genome Biology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0160","first-page":"5061","article-title":"The potential tumor suppressor p73 differentially regulates cellular p53 target genes","volume":"58","author":"Zhu","year":"1998","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0165","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrc861","article-title":"p73: friend or foe in tumorigenesis","volume":"2","author":"Melino","year":"2002","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0170","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1038\/sj.onc.1206859","article-title":"Differential regulation of p63 and p73 expression","volume":"22","author":"Waltermann","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0175","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.cdd.4401376","article-title":"DNA damage induces the rapid and selective degradation of the Delta Np73 isoform, allowing apoptosis to occur","volume":"11","author":"Maisse","year":"2004","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0180","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2409::AID-CNCR15>3.0.CO;2-T","article-title":"Expression of p21WAF1\/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis","volume":"82","author":"Lu","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/gyno.2000.5879","article-title":"Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27 (Kip1)","volume":"78","author":"Farley","year":"2000","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s004280100439","article-title":"Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas","volume":"439","author":"Milde-Langosch","year":"2001","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/gyno.2002.6858","article-title":"Evaluation of p27 in preinvasive and invasive malignancies of the cervix","volume":"88","author":"Goff","year":"2003","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0090-8258(03)00010-6","article-title":"Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis","volume":"89","author":"van de Putte","year":"2003","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0205","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/cncr.11727","volume":"98","author":"Alfsen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0210","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijrobp.2004.02.032","article-title":"Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis","volume":"60","author":"Suzuki","year":"2004","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2008.09.013","article-title":"Pitfalls in immunohistochemical validation of tumor marker expression\u2014exemplified in invasive cancer of the uterine cervix","volume":"112","author":"Hellberg","year":"2009","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0220","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ijrobp.2008.09.005","article-title":"Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer","volume":"74","author":"Yamashita","year":"2009","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0225","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00428-005-1252-0","article-title":"Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease","volume":"446","author":"Shiohara","year":"2005","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2003.10.022","article-title":"Cyclins and proliferation markers in early squamous cervical carcinoma","volume":"92","author":"Van de Putte","year":"2004","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0235","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/gyno.2001.6196","article-title":"Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus","volume":"81","author":"Bae","year":"2001","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0240","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/bjc.1998.466","article-title":"Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer","volume":"78","author":"Crawford","year":"1998","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0245","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/PAT.0b013e3283484a3a","article-title":"Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix","volume":"43","author":"Moon","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0250","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1447-0756.2010.01227.x","article-title":"Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas","volume":"36","author":"Hanprasertpong","year":"2010","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0255","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1158\/1078-0432.CCR-05-2573","article-title":"Expression of deltaNp73 and TAp73alpha independently associated with radiosensitivities and prognoses in cervical squamous cell carcinoma","volume":"12","author":"Liu","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0260","first-page":"48","article-title":"Prognostic value of p53 expression in early stage cervical carcinoma treated by surgery","volume":"9","author":"Khunamornpong","year":"2008","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0265","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0301-2115(00)00541-8","article-title":"The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer","volume":"97","author":"Tjalma","year":"2001","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0270","first-page":"577","article-title":"Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis","volume":"5","author":"Kersemaekers","year":"1999","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0275","first-page":"6629","article-title":"Identification of ciap1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas","volume":"61","author":"Imoto","year":"2001","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0280","first-page":"4860","article-title":"Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy","volume":"62","author":"Imoto","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0285","first-page":"662","article-title":"Expression of survivin, caspase-3 and p53 in cervical cancer assessed by tissue microarray: correlation with clinicopathology and prognosis","volume":"31","author":"Lu","year":"2010","journal-title":"European Journal of Gynaecological Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0290","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF02831393","article-title":"Expression of survivin, cyclinD1, p21(WAF1), caspase-3 in cervical cancer and its relation with prognosis","volume":"25","author":"Lu","year":"2005","journal-title":"Journal of Huazhong University of Science and Technology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","article-title":"Review of epidermal growth factor receptor biology","volume":"59","author":"Herbst","year":"2004","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0305","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0310","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0315","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/1078-0432.CCR-0497-03","article-title":"Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival","volume":"10","author":"Kim","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0320","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1158\/1078-0432.CCR-09-1149","article-title":"Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer","volume":"15","author":"Noordhuis","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0325","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdq723","article-title":"Epidermal growth factor receptor as a biomarker for cervical cancer","volume":"22","author":"Soonthornthum","year":"2011","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0330","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/gyno.2002.6803","article-title":"Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma","volume":"87","author":"Kim","year":"2002","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0335","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<513::AID-CNCR13>3.0.CO;2-6","article-title":"Correlation of cervical carcinoma c-erb B-2 oncogene with cell proliferation parameters in patients treated with radiation therapy for cervical carcinoma","volume":"79","author":"Nakano","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0340","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/sj.bjc.6603180","article-title":"Increased expression of pAKT is associated with radiation resistance in cervical cancer","volume":"94","author":"Kim","year":"2006","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0345","first-page":"57","article-title":"Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy","volume":"16","author":"Faried","year":"2006","journal-title":"Oncology Reports"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0350","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/mc.20402","article-title":"Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: a potential biomarker and molecular target therapy","volume":"47","author":"Faried","year":"2008","journal-title":"Molecular Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0355","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/bjc.2011.222","article-title":"EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target","volume":"105","author":"Iida","year":"2011","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0360","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ygyno.2004.01.006","article-title":"Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis","volume":"93","author":"Lee","year":"2004","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0365","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/COC.0b013e3181e84634","article-title":"Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy","volume":"34","author":"P\u00e9rez-Regadera","year":"2011","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0370","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1525-1438.2007.01111.x","article-title":"Absence of epidermal growth factor receptor mutations in cervical cancer","volume":"18","author":"Arias-Pulido","year":"2008","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0375","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1471-2407-9-212","article-title":"Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma","volume":"9","author":"Longatto-Filho","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0380","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0090-8258(03)00504-3","article-title":"P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma","volume":"91","author":"Cho","year":"2003","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0385","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0360-3016(03)00209-8","article-title":"Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy","volume":"56","author":"Gaffney","year":"2003","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0390","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3835(97)00421-7","article-title":"Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer","volume":"123","author":"Scambia","year":"1998","journal-title":"Cancer Letters"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0395","first-page":"493","article-title":"Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix","volume":"44","author":"Hove","year":"1999","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0400","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.1999.5346","article-title":"Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas","volume":"73","author":"Skomedal","year":"1999","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0405","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000050613","article-title":"Abnormal expression of epidermal growth factor receptor and c-erbB2 in squamous cell carcinoma of the cervix: correlation with human papillomavirus and prognosis","volume":"22","author":"Ngan","year":"2001","journal-title":"Tumour Biology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0410","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/pgp.0b013e31802f1996","article-title":"Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas","volume":"26","author":"Baltazar","year":"2007","journal-title":"International Journal of Gynecological Pathology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0415","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.2967\/jnumed.108.052316","article-title":"Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell lines","volume":"49","author":"Eiblmaier","year":"2008","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0420","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2011.05.040","article-title":"Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"122","author":"Santin","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0425","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2011.01.030","article-title":"Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study","volume":"121","author":"Farley","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0430","first-page":"885","article-title":"Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction","volume":"8","author":"Gupta","year":"2002","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0435","first-page":"2241","article-title":"Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer","volume":"9","author":"Blackhall","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0440","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2005.05.045","article-title":"Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix","volume":"99","author":"Lee","year":"2005","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0445","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1471-2407-8-295","article-title":"Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy","volume":"8","author":"Choi","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0450","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1054\/bjoc.2000.1319","article-title":"Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix","volume":"5","author":"Loncaster","year":"2000","journal-title":"British Journal of Cancer"},{"issue":"5 Pt 1","key":"10.1016\/j.critrevonc.2012.09.003_bib0455","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0029-7844(00)01025-5","article-title":"Vascular endothelial growth factor and prognosis of cervical carcinoma","volume":"96","author":"Cheng","year":"2000","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0460","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ygyno.2010.07.035","article-title":"VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival","volume":"119","author":"Kim","year":"2010","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0465","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1756-9966-28-98","article-title":"The role of VEGF-C\/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma","volume":"28","author":"Yu","year":"2009","journal-title":"Journal of Experimental and Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0470","article-title":"Interaction of tumor cells and lymphatic vessels in cancer progression","author":"Alitalo","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0475","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1054\/bjoc.2001.1846","article-title":"Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer","volume":"85","author":"Hashimoto","year":"2001","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0480","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0485","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI9621","article-title":"Host cyclooxygenase-2 modulates carcinoma growth","volume":"105","author":"Williams","year":"2000","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0490","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/gyno.1999.5690","article-title":"High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion","volume":"76","author":"Ryu","year":"2000","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0495","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ijrobp.2004.04.030","article-title":"Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix","volume":"60","author":"Kim","year":"2004","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0500","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejogrb.2009.09.011","article-title":"Prevalence and clinical relevance of cyclooxygenase-1 and -2 expression in stage IIB cervical adenocarcinoma","volume":"148","author":"Jung","year":"2010","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0505","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.20.4.973","article-title":"Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients","volume":"20","author":"Ferrandina","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0510","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cncr.10684","article-title":"Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy","volume":"95","author":"Kim","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0515","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0360-3016(00)01583-2","article-title":"Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy","volume":"49","author":"Gaffney","year":"2001","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0520","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ijrobp.2004.10.044","article-title":"Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy","volume":"62","author":"Pyo","year":"2005","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0525","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/1078-0432.CCR-1090-3","article-title":"Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer","volume":"10","author":"Ferrandina","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0530","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Zhong","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0535","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0540","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0545","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.bjc.6603597","article-title":"Stat3 activation in human endometrial and cervical cancers","volume":"96","author":"Chen","year":"2007","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0550","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.bjc.6605212","article-title":"Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma","volume":"101","author":"Takemoto","year":"2009","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0555","doi-asserted-by":"crossref","first-page":"32979","DOI":"10.1074\/jbc.M502694200","article-title":"A novel platinum compound inhibits constitutive Stat3 signalling and induces cell cycle arrest and apoptosis of malignant cells","volume":"280","author":"Turkson","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0560","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/sj.onc.1208316","article-title":"In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy","volume":"24","author":"Xi","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0565","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/ijc.25935","article-title":"Autocrine\/paracrine erythropoietin signalling promotes JAK\/STAT-dependent proliferation of human cervical cancer cells","volume":"129","author":"Lopez","year":"2011","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0570","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1200\/JCO.2010.30.4899","article-title":"Randomized phase III trial of sequential adjuvant chemoradiotherapy with or without erythropoietin Alfa in patients with high-risk cervical cancer: results of the NOGGO-AGO intergroup study","volume":"29","author":"Blohmer","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0575","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrm1130","article-title":"Fibulins: a versatile family of extracellular matrix proteins","volume":"4","author":"Timpl","year":"2003","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0580","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygyno.2010.11.004","article-title":"EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo","volume":"121","author":"Song","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0585","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ygyno.2009.12.016","article-title":"The expression of EFEMP1 in cervical carcinoma and its relationship with prognosis","volume":"117","author":"En-lin","year":"2010","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0590","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.yexcr.2005.03.001","article-title":"Mechanisms of gelsolin-dependent and -independent EGF-stimulated cell motility in a human lung epithelial cell line","volume":"307","author":"Lader","year":"2005","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0595","first-page":"35","article-title":"Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance","volume":"1201","author":"Liao","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0600","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.24075","article-title":"Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype","volume":"124","author":"de Cremoux","year":"2009","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0605","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/88.19.1361","article-title":"Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer","volume":"88","author":"Burger","year":"1996","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0610","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1200\/JCO.1998.16.8.2613","article-title":"Human papillomavirus genotype as a major determinant of the course of cervical cancer","volume":"16","author":"Lombard","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0615","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1200\/JCO.2001.19.7.1906","article-title":"Human papillomavirus and prognosis of invasive cervical cancer: a population-based study","volume":"19","author":"Schwartz","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0620","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1200\/JCO.2007.11.2995","article-title":"Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery","volume":"25","author":"Lai","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0625","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2011.01.015","article-title":"HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy","volume":"121","author":"Kang","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0630","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1525-1438.2001.011001039.x","article-title":"The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University","volume":"11","author":"Pilch","year":"2001","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0635","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/379088a0","article-title":"Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours","volume":"379","author":"Graeber","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0640","first-page":"941","article-title":"Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma","volume":"56","author":"Brizel","year":"1996","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0645","first-page":"5754","article-title":"Genetic instability induced by the tumor microenvironment","volume":"56","author":"Reynolds","year":"1996","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0650","first-page":"3316","article-title":"Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements","volume":"51","author":"Vaupel","year":"1991","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0655","first-page":"6098","article-title":"Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements","volume":"51","author":"H\u00f6ckel","year":"1991","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0660","first-page":"4509","article-title":"Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix","volume":"56","author":"H\u00f6ckel","year":"1996","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0665","first-page":"4525","article-title":"Hypoxic cervical cancers with low apoptotic index are highly aggressive","volume":"59","author":"Hockel","year":"1999","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0670","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1200\/JCO.20.3.680","article-title":"Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer","volume":"20","author":"Fyles","year":"2002","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0675","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-8140(99)00139-5","article-title":"Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix","volume":"53","author":"Knocke","year":"1999","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0680","first-page":"1104","article-title":"Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy","volume":"6","author":"Lyng","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0685","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1097-0215(19980821)79:4<365::AID-IJC10>3.0.CO;2-4","article-title":"Tumor hypoxia in pelvic recurrences of cervical cancer","volume":"79","author":"H\u00f6ckel","year":"1998","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0690","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/bjc.1995.532","article-title":"Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumors","volume":"72","author":"Horseman","year":"1995","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0695","first-page":"928","article-title":"Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix","volume":"7","author":"Airley","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0700","first-page":"916","article-title":"High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers","volume":"60","author":"Walenta","year":"2000","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0705","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1074\/jbc.272.9.5555","article-title":"Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation","volume":"272","author":"Behrooz","year":"1997","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0710","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer","volume":"158","author":"Ivanov","year":"2001","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0715","first-page":"6394","article-title":"Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix","volume":"61","author":"Loncaster","year":"2001","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0720","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0725","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2009.10.062","article-title":"Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study","volume":"116","author":"Liao","year":"2010","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0730","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/00313029600169274","article-title":"Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study","volume":"28","author":"Bethwaite","year":"1996","journal-title":"Pathology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0735","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/bjc.1997.560","article-title":"Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions","volume":"76","author":"Bontkes","year":"1997","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0740","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc700","article-title":"Immune evasion in human papillomavirus-associated cervical cancer","volume":"2","author":"Tindle","year":"2002","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0745","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/gyno.2001.6378","article-title":"Cytokine profile of cervical cancer cells","volume":"83","author":"Hazelbag","year":"2001","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0750","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/ijc.20512","article-title":"Prognostic relevance of TGF-\u03b21 and PAI-1 in cervical cancer","volume":"112","author":"Hazelbag","year":"2004","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0755","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0074-7696(07)56005-5","article-title":"MHC class I antigens and immune surveillance in transformed cells","volume":"256","author":"Aptsiauri","year":"2007","journal-title":"International Review of Cytology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0760","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00005-008-0018-1","article-title":"The significance of Treg cells in defective tumor immunity","volume":"56","author":"Kosmaczewska","year":"2008","journal-title":"Arch Immunol Ther Exp."},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0765","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1034\/j.1399-0039.2000.550502.x","article-title":"Multiple mechanisms underlie HLA dysregulation in cervical cancer","volume":"55","author":"Brady","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0770","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.191.6.961","article-title":"Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer","volume":"191","author":"Koopman","year":"2000","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0775","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2007.08.089","article-title":"A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years","volume":"108","author":"Nedergaard","year":"2008","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0780","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1084\/jem.179.1.335","article-title":"Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas","volume":"179","author":"Cromme","year":"1994","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0785","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00262-007-0362-8","article-title":"Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma","volume":"57","author":"Mehta","year":"2008","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0790","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/1078-0432.CCR-07-4554","article-title":"Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+\/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?","volume":"14","author":"Jordanova","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0795","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/cmi.2010.56","article-title":"A reversed CD4\/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix","volume":"8","author":"Shah","year":"2011","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0800","first-page":"1079","article-title":"Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer","volume":"6","author":"Harima","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0805","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ijc.1027","article-title":"Chromosome 6p21.2, 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy","volume":"96","author":"Harima","year":"2001","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0810","first-page":"440","article-title":"Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy","volume":"53","author":"Kozlowski","year":"2006","journal-title":"Neoplasma"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0815","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"van\u2019t Veer","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0820","first-page":"518","article-title":"Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs","volume":"62","author":"Zembutsu","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0825","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1158\/1078-0432.CCR-05-0835","article-title":"Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray","volume":"12","author":"Bidus","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0830","first-page":"5486","article-title":"Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray","volume":"9","author":"Wong","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0835","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1471-2164-7-268","article-title":"Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer","volume":"7","author":"Lyng","year":"2006","journal-title":"BMC Genomics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0840","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2007.11.024","article-title":"Gene expression in early stage cervical cancer","volume":"108","author":"Biewenga","year":"2008","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0845","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijrobp.2007.10.068","article-title":"Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome","volume":"71","author":"Klopp","year":"2008","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0850","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ijrobp.2009.07.002","article-title":"Identification of genes associated with progression and metastasis of advanced cervical cancers after radiotherapy by cDNA microarray analysis","volume":"75","author":"Harima","year":"2009","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0855","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1002\/cncr.25870","article-title":"Identification of a gene-expression signature for predicting lymph node metastasis in patients with early stage cervical carcinoma","volume":"117","author":"Huang","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0860","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0865","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-07-1083","article-title":"The let-7 microRNA represses cell proliferation pathways in human cells","volume":"67","author":"Johnson","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0870","doi-asserted-by":"crossref","first-page":"14910","DOI":"10.1074\/jbc.C800074200","article-title":"The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2","volume":"283","author":"Korpal","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0875","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1470-2045(11)70012-2","article-title":"Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections","volume":"12","author":"Marchini","year":"2011","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0880","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ijrobp.2011.09.030","article-title":"A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"83","author":"Della Vittoria Scarpati","year":"2012","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0885","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1158\/1078-0432.CCR-07-1231","article-title":"Altered MicroRNA expression in cervical carcinomas","volume":"14","author":"Lee","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0890","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1158\/0008-5472.CAN-06-0561","article-title":"Patterns of known and novel small RNAs in human cervical cancer","volume":"67","author":"Lui","year":"2007","journal-title":"Cancer Research"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.09.003_bib0895","doi-asserted-by":"crossref","first-page":"e2557","DOI":"10.1371\/journal.pone.0002557","article-title":"Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth","volume":"3","author":"Wang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0900","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1177\/147323001003800518","article-title":"High-risk human papillomavirus reduces the expression of microRNA-218 in women with cervical intraepithelial neoplasia","volume":"38","author":"Li","year":"2010","journal-title":"Journal of International Medical Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0905","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/0008-5472.CAN-09-3289","article-title":"A microRNA expression signature for cervical cancer prognosis","volume":"70","author":"Hu","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0910","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2011.03.032","article-title":"Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population","volume":"122","author":"Yue","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0915","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.ajpath.2011.07.037","article-title":"miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1","volume":"179","author":"Wang","year":"2011","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0920","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2010.09.009","article-title":"MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells","volume":"120","author":"Li","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0925","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/bjc.2012.109","article-title":"The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer","volume":"106","author":"Lajer","year":"2012","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0930","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.febslet.2012.02.020","article-title":"miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells","volume":"586","author":"Kang","year":"2012","journal-title":"FEBS Letters"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0935","first-page":"753","article-title":"miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2","volume":"5","author":"Liu","year":"2012","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0940","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1073\/pnas.93.6.2239","article-title":"The molecular biology of apoptosis","volume":"93","author":"Vaux","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0945","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2010.09.043","article-title":"Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: a systematic review","volume":"79","author":"Noordhuis","year":"2011","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0950","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2012.04.007","article-title":"Molecularly targeted therapies in cervical cancer. A systematic review","volume":"126","author":"Zagouri","year":"2012","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0955","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1038\/sj.onc.1203817","article-title":"Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner","volume":"19","author":"L\u00f3pez-Ocejo","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2012.09.003_bib0960","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/sj.onc.1207442","article-title":"Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors","volume":"23","author":"Toussaint-Smith","year":"2004","journal-title":"Oncogene"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842812001862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842812001862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T08:40:04Z","timestamp":1562229604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842812001862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":192,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1040842812001862"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2012.09.003","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}